Background: Remote structural and functional changes have been previously described after stroke and may have an impact on clinical outcome. We aimed to use multimodal MRI to investigate contralesional subcortical structural and functional changes 3 months after anterior circulation ischemic stroke. Methods: Fifteen patients with acute ischemic stroke had multimodal MRI imaging (including high resolution structural T1-MPRAGE and resting state fMRI) within 1 week of onset and at 1 and 3 months. Seven healthy controls of similar age group were also imaged at a single time point. Contralesional subcortical structural volume was assessed using an automated segmentation algorithm in FMRIB's Integrated Registration and Segmentation Tool (FIRST). Functional connectivity changes were assessed using the intrinsic connectivity contrast (ICC), which was calculated using the functional connectivity toolbox for correlated and anticorrelated networks (Conn). Results: Contralesional thalamic volume in the stroke patients was significantly reduced at 3 months compared to baseline (median change -2.1%, interquartile range [IQR] -3.4-0.4, p = 0.047), with the predominant areas demonstrating atrophy geometrically appearing to be the superior and inferior surface. The difference in volume between the contralesional thalamus at baseline (mean 6.41 ml, standard deviation [SD] 0.6 ml) and the mean volume of the 2 thalami in controls (mean 7.22 ml, SD 1.1 ml) was not statistically significant. The degree of longitudinal thalamic atrophy in patients was correlated with baseline stroke severity with more severe strokes being associated with a greater degree of atrophy (Spearman's rho -0.54, p = 0.037). There was no significant difference between baseline contralesional thalamic ICC in patients and control thalamic ICC. However, in patients, there was a significant linear reduction in the mean ICC of the contralesional thalamus over the imaging time points (p = 0.041), indicating reduced connectivity to the remainder of the brain. Conclusions: These findings highlight the importance of remote brain areas, such as the contralesional thalamus, in stroke recovery. Similar methods have the potential to be used in the prediction of stroke outcome or as imaging biomarkers of stroke recovery.

Keywords:
Stroke, Ischemic stroke, Magnetic resonance imaging, fMRI, Stroke recovery, Thalamus
1.
Baron JC, Bousser MG, Comar D, Castaigne P: ‘Crossed cerebellar diaschisis' in human supratentorial brain infarction. Trans Am Neurol Assoc 1981;105:459-461.
2.
Tamura A, Tahira Y, Nagashima H, Kirino T, Gotoh O, Hojo S, Sano K: Thalamic atrophy following cerebral infarction in the territory of the middle cerebral artery. Stroke 1991;22:615-618.
3.
Infeld B, Davis SM, Lichtenstein M, Mitchell PJ, Hopper JL: Crossed cerebellar diaschisis and brain recovery after stroke. Stroke 1995;26:90-95.
4.
Sobesky J, Thiel A, Ghaemi M, Hilker RH, Rudolf J, Jacobs AH, Herholz K, Heiss WD: Crossed cerebellar diaschisis in acute human stroke: a PET study of serial changes and response to supratentorial reperfusion. J Cereb Blood Flow Metab 2005;25:1685-1691.
5.
Liu Y, Karonen JO, Nuutinen J, Vanninen E, Kuikka JT, Vanninen RL: Crossed cerebellar diaschisis in acute ischemic stroke: a study with serial SPECT and MRI. J Cereb Blood Flow Metab 2007;27:1724-1732.
6.
Lin DD, Kleinman JT, Wityk RJ, Gottesman RF, Hillis AE, Lee AW, Barker PB: Crossed cerebellar diaschisis in acute stroke detected by dynamic susceptibility contrast MR perfusion imaging. AJNR Am J Neuroradiol 2009;30:710-715.
7.
Jeon YW, Kim SH, Lee JY, Whang K, Kim MS, Kim YJ, Lee MS; Brain Research Group: Dynamic CT perfusion imaging for the detection of crossed cerebellar diaschisis in acute ischemic stroke. Korean J Radiol 2012;13:12-19.
8.
Dani KA, Santosh C, Brennan D, Hadley DM, Muir KW: Crossed cerebellar diaschisis: insights into oxygen challenge MRI. J Cereb Blood Flow Metab 2012;32:2114-2117.
9.
Gauthier LV, Taub E, Mark VW, Barghi A, Uswatte G: Atrophy of spared gray matter tissue predicts poorer motor recovery and rehabilitation response in chronic stroke. Stroke 2012;43:453-457.
10.
Kraemer M, Schormann T, Hagemann G, Qi B, Witte OW, Seitz RJ: Delayed shrinkage of the brain after ischemic stroke: preliminary observations with voxel-guided morphometry. J Neuroimaging 2004;14:265-272.
11.
Dang C, Liu G, Xing S, Xie C, Peng K, Li C, Li J, Zhang J, Chen L, Pei Z, Zeng J: Longitudinal cortical volume changes correlate with motor recovery in patients after acute local subcortical infarction. Stroke 2013;44:2795-2801.
12.
Brodtmann A, Pardoe H, Li Q, Lichter R, Ostergaard L, Cumming T: Changes in regional brain volume three months after stroke. J Neurol Sci 2012;322:122-128.
13.
Wang X, Valdes Hernandez MC, Doubal F, Chappell FM, Wardlaw JM: How much do focal infarcts distort white matter lesions and global cerebral atrophy measures? Cerebrovasc Dis 2012;34:336-342.
14.
Detre JA, Wang J: Technical aspects and utility of fMRI using BOLD and ASL. Clin Neurophysiol 2002;113:621-634.
15.
Murata Y, Sakatani K, Hoshino T, Fujiwara N, Kano T, Nakamura S, Katayama Y: Effects of cerebral ischemia on evoked cerebral blood oxygenation responses and BOLD contrast functional MRI in stroke patients. Stroke 2006;37:2514-2520.
16.
Battaglini M, Jenkinson M, De Stefano N: Evaluating and reducing the impact of white matter lesions on brain volume measurements. Hum Brain Mapp 2012;33:2062-2071.
17.
Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, et al: Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1):S208-S219.
18.
Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM: FSL. Neuroimage 2012;62:782-790.
19.
Winkler AM, Ridgway GR, Webster MA, Smith SM, Nichols TE: Permutation inference for the general linear model. Neuroimage 2014;92:381-397.
20.
Smith SM, Nichols TE: Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 2009;44:83-98.
21.
Whitfield-Gabrieli S, Nieto-Castanon A: Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect 2012;2:125-141.
22.
Behzadi Y, Restom K, Liau J, Liu TT: A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. Neuroimage 2007;37:90-101.
23.
Martuzzi R, Ramani R, Qiu M, Shen X, Papademetris X, Constable RT: A whole-brain voxel based measure of intrinsic connectivity contrast reveals local changes in tissue connectivity with anesthetic without a priori assumptions on thresholds or regions of interest. Neuroimage 2011;58:1044-1050.
24.
Miles J, Shevlin M: Applying Regression and Correlation: A Guide for Students and Researchers. Sage, 2001, p 272.
25.
Feeney DM, Baron JC: Diaschisis. Stroke 1986;17:817-830.
26.
Baron JC, Levasseur M, Mazoyer B, Legault-Demare F, Mauguiere F, Pappata S, Jedynak P, Derome P, Cambier J, Tran-Dinh S, et al: Thalamocortical diaschisis: positron emission tomography in humans. J Neurol Neurosurg Psychiatry 1992;55:935-942.
27.
Carmichael ST, Tatsukawa K, Katsman D, Tsuyuguchi N, Kornblum HI: Evolution of diaschisis in a focal stroke model. Stroke 2004;35:758-763.
28.
Celesia GG, Polcyn RE, Holden JE, Nickles RJ, Koeppe RA, Gatley SJ: Determination of regional cerebral blood flow in patients with cerebral infarction. Use of fluoromethane labeled with fluorine 18 and positron emission tomography. Arch Neurol 1984;41:262-267.
29.
Kuhl DE, Phelps ME, Kowell AP, Metter EJ, Selin C, Winter J: Effects of stroke on local cerebral metabolism and perfusion: mapping by emission computed tomography of 18FDG and 13NH3. Ann Neurol 1980;8:47-60.
30.
Seitz RJ, Azari NP, Knorr U, Binkofski F, Herzog H, Freund HJ: The role of diaschisis in stroke recovery. Stroke 1999;30:1844-1850.
31.
Carey LM, Abbott DF, Harvey MR, Puce A, Seitz RJ, Donnan GA: Relationship between touch impairment and brain activation after lesions of subcortical and cortical somatosensory regions. Neurorehabil Neural Repair 2011;25:443-457.
32.
Fujie W, Kirino T, Tomukai N, Iwasawa T, Tamura A: Progressive shrinkage of the thalamus following middle cerebral artery occlusion in rats. Stroke 1990;21:1485-1488.
33.
Preuss TM, Goldman‐Rakic PS: Crossed corticothalamic and thalamocortical connections of macaque prefrontal cortex. J Comp Neurol 1987;257:269-281.
34.
Dermon CR, Barbas H: Contralateral thalamic projections predominantly reach transitional cortices in the rhesus monkey. J Comp Neurol 1994;344:508-531.
35.
Andrews RJ: Transhemispheric diaschisis. A review and comment. Stroke 1991;22:943-949.
36.
Gupta RK, Saksena S, Hasan KM, Agarwal A, Haris M, Pandey CM, Narayana PA: Focal Wallerian degeneration of the corpus callosum in large middle cerebral artery stroke: serial diffusion tensor imaging. J Magn Reson Imaging 2006;24:549-555.
37.
Strassburger TL, Lee HC, Daly EM, Szczepanik J, Krasuski JS, Mentis MJ, Salerno JA, DeCarli C, Schapiro MB, Alexander GE: Interactive effects of age and hypertension on volumes of brain structures. Stroke 1997;28:1410-1417.
38.
Northam EA, Rankins D, Lin A, Wellard RM, Pell GS, Finch SJ, Werther GA, Cameron FJ: Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 2009;32:445-450.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.